These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8005112)

  • 1. Clinical epidemiology and experimental biology in cardiology: the two faces of the same coin.
    de Lorgeril M; Renaud S
    Eur Heart J; 1994 Feb; 15(2):156-7. PubMed ID: 8005112
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Cheng TO
    Cardiology; 1996; 87(3):267. PubMed ID: 8801029
    [No Abstract]   [Full Text] [Related]  

  • 3. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 4. Update of recent clinical trials in heart failure and myocardial infarction.
    Richardson M; Cockburn N; Cleland JG
    Eur J Heart Fail; 1999 Mar; 1(1):109-15. PubMed ID: 10937988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
    McMurray JJ
    Heart; 2001 Jul; 86(1):97-103. PubMed ID: 11410575
    [No Abstract]   [Full Text] [Related]  

  • 7. What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
    Dickstein K
    Am Heart J; 2003 May; 145(5):754-7. PubMed ID: 12766730
    [No Abstract]   [Full Text] [Related]  

  • 8. ACE inhibitor therapy: benefits and underuse.
    Smith SC
    Am Fam Physician; 1999 Jan; 59(1):35-6, 38. PubMed ID: 9917572
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACE inhibitors early after myocardial infarct].
    Heinzl S
    Med Monatsschr Pharm; 1994 Jul; 17(7):197. PubMed ID: 8090131
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
    Swedberg K; McMurray JJ
    Eur Heart J; 2004 Mar; 25(5):357-8. PubMed ID: 15033244
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibition: from viper to patient.
    Komajda M; Wimart MC
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i11-4:discussion i50. PubMed ID: 10956312
    [No Abstract]   [Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 14. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments pro].
    de Teresa E
    Rev Esp Cardiol; 1994 Nov; 47(11):723-8. PubMed ID: 7800901
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments contra].
    Rodríguez Lambert JL; Moris C
    Rev Esp Cardiol; 1994 Nov; 47(11):719-22. PubMed ID: 7800900
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary prevention: improving outcomes following myocardial infarction.
    Maggioni AP
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i5-7:discussion i50. PubMed ID: 10956310
    [No Abstract]   [Full Text] [Related]  

  • 18. Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?
    Sigurdsson A; Swedberg K
    Br Heart J; 1994 Sep; 72(3 Suppl):S75-80. PubMed ID: 7946809
    [No Abstract]   [Full Text] [Related]  

  • 19. ACE inhibitors for congestive heart failure.
    Med Lett Drugs Ther; 1988 Oct; 30(777):97-8. PubMed ID: 3173235
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction.
    Swedberg K; Sharpe N
    Eur Heart J; 1996 Sep; 17(9):1306-11. PubMed ID: 8880014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.